Obesity and Kidney Transplantation

Seminars in Nephrology

Volumn 33, Issue 1, 2013, Pages 34-43

  Srinivas, Titte R ^a   Meier Kriesche, Herwig Ulf ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

Author keywords

Metabolic syndrome; Outcomes; Overweight; Renal allograft; Risk factors

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SIBUTRAMINE; SULFONYLUREA; TACROLIMUS; TETRAHYDROLIPSTATIN;

ARTICLE; BARIATRIC SURGERY; BODY COMPOSITION; BODY MASS; DEEP VEIN THROMBOSIS; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; DIET THERAPY; DRUG ABSORPTION; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HERNIA; HOSPITAL ADMISSION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INDIVIDUALIZATION; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STOMACH BYPASS; TREATMENT OUTCOME; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; WOUND HEALING IMPAIRMENT;

DELAYED GRAFT FUNCTION; HUMANS; KIDNEY TRANSPLANTATION; OBESITY; POSTOPERATIVE COMPLICATIONS;

EID: 84873122296     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2012.12.007     Document Type: Article

References (51)

1. Friedman A.N., Miskulin D.C., Rosenberg I.H., Levey A.S. Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis 2003, 41:480-487.
2. Johnson C.P., Gallagher-Lepak S., Zhu Y.R., et al. Factors influencing weight gain after renal transplantation. Transplantation 1993, 56:822-827.
3. Calle E.E., Thun M.J., Petrelli J.M., Rodriguez C., Heath C.W. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999, 341:1097-1105.
4. Kovesdy C.P., Czira M.E., Rudas A., et al. Body mass index, waist circumference and mortality in kidney transplant recipients. Am J Transplant 2010, 10:2644-2651.
5. Schutz T., Hudjetz H., Roske A.E., et al. Weight gain in long-term survivors of kidney or liver transplantation-another paradigm of sarcopenic obesity?. Nutrition 2012, 28:378-383.
6. Gregg E.W., Cheng Y.J., Cadwell B.L., et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005, 293:1868-1874.
7. Fleischmann E.H., Bower J.D., Salahudeen A.K. Risk factor paradox in hemodialysis: better nutrition as a partial explanation. Asaio J 2001, 47:74-81.
8. Kalantar-Zadeh K., Kuwae N., Wu D.Y., et al. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 2006, 83:202-210.
9. Schindler T.H., Cardenas J., Prior J.O., et al. Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol 2006, 47:1188-1195.
10. Bonnet F., Deprele C., Sassolas A., et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 2001, 37:720-727.
11. Kambham N., Markowitz G.S., Valeri A.M., Lin J., D'Agati V.D. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001, 59:1498-1509.
12. Praga M., Hernandez E., Herrero J.C., et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 2000, 58:2111-2118.
13. Brenner B.M., Cohen R.A., Milford E.L. In renal transplantation, one size may not fit all. J Am Soc Nephrol 1992, 3:162-169.
14. Kaplan B., Srinivas T.R., Meier-Kriesche H.U. Factors associated with long-term renal allograft survival. Ther Drug Monit 2002, 24:36-39.
15. Yee G.K. Cyclosporine. Applied pharmacokinetics 1986, Applied Therapeutics, Spokane. W.S. Evans, W. Jusko (Eds.).
16. Johnson D.W., Isbel N.M., Brown A.M., et al. The effect of obesity on renal transplant outcomes. Transplantation 2002, 74:675-681.
17. Humar A., Ramcharan T., Denny R., Gillingham K.J., Payne W.D., Matas A.J. Are wound complications after a kidney transplant more common with modern immunosuppression?. Transplantation 2001, 72:1920-1923.
18. Bennett W.M., McEvoy K.M., Henell K.R., Valente J.F., Douzdjian V. Morbid obesity does not preclude successful renal transplantation. Clin Transplant 2004, 18:89-93.
19. Gill I.S., Hodge E.E., Novick A.C., Steinmuller D.R., Garred D. Impact of obesity on renal transplantation. Transplant Proc 1993, 25:1047-1048.
20. Modlin C.S., Flechner S.M., Goormastic M., et al. Should obese patients lose weight before receiving a kidney transplant?. Transplantation 1997, 64:599-604.
21. Howard R.J., Thai V.B., Patton P.R., et al. Obesity does not portend a bad outcome for kidney transplant recipients. Transplantation 2002, 73:53-55.
22. Meier-Kriesche H.U., Arndorfer J.A., Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002, 73:70-74.
23. Molnar M.Z., Kovesdy C.P., Mucsi I., et al. Higher recipient body mass index is associated with post-transplant delayed kidney graft function. Kidney Int 2011, 80:218-224.
24. Meier-Kriesche H.U., Vaghela M., Thambuganipalle R., Friedman G., Jacobs M., Kaplan B. The effect of body mass index on long-term renal allograft survival. Transplantation 1999, 68:1294-1297.
25. Merion R.M., Twork A.M., Rosenberg L., et al. Obesity and renal transplantation. Surg Gynecol Obstet 1991, 172:367-376.
26. Kasiske B.L., Anjum S., Shah R., et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004, 43:1071-1081.
27. Kasiske B.L., Maclean J.R., Snyder J.J. Acute myocardial infarction and kidney transplantation. J Am Soc Nephrol 2006, 17:900-907.
28. Kasiske B.L. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients. Am J Transplant 2005, 5:1576.
29. Rao K.V., Andersen R.C. Long-term results and complications in renal transplant recipients. Observations in the second decade. Transplantation 1988, 45:45-52.
30. Carvalho M.F., Soares V. Hyperlipidemia as a risk factor of renal allograft function impairment. Clin Transplant 2001, 15:48-52.
31. Holdaas H., Fellstrom B., Cole E., et al. Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study. Am J Transplant 2005, 5:2929-2936.
32. Hjelmesaeth J., Jenssen T., Hagen M., Egeland T., Hartmann A. Determinants of insulin secretion after renal transplantation. Metabolism 2003, 52:573-578.
33. Kasiske B.L., Snyder J.J., Gilbertson D., Matas A.J. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003, 3(2):178-185.
34. Cosio F.G., Pesavento T.E., Kim S., Osei K., Henry M., Ferguson R.M. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002, 62:1440-1446.
35. Cosio F.G., Kudva Y., van der Velde M., et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005, 67:2415-2421.
36. Gore J.L., Pham P.T., Danovitch G.M., et al. Obesity and outcome following renal transplantation. Am J Transplant 2006, 6:357-363.
37. Armstrong K.A., Campbell S.B., Hawley C.M., Nicol D.L., Johnson D.W., Isbel N.M. Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients. Am J Transplant 2005, 5:2710-2718.
38. Baum C.L., Thielke K., Westin E., Kogan E., Cicalese L., Benedetti E. Predictors of weight gain and cardiovascular risk in a cohort of racially diverse kidney transplant recipients. Nutrition 2002, 18:139-146.
39. van den Ham E.C., Kooman J.P., Christiaans M.H., Nieman F.H., van Hooff J.P. Weight changes after renal transplantation: a comparison between patients on 5-mg maintenance steroid therapy and those on steroid-free immunosuppressive therapy. Transpl Int 2003, 16:300-306.
40. Woodle E.S., First M.R., Pirsch J., Shihab F., Gaber A.O., Van Veldhuisen P. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 2008, 248:564-577.
41. Feldman H.I., Fazio I., Roth D., et al. Recipient body size and cadaveric renal allograft survival. J Am Soc Nephrol 1996, 7:151-157.
42. Schold J.D., Srinivas T.R., Guerra G., et al. A "weight-listing" paradox for candidates of renal transplantation?. Am J Transplant 2007, 7:550-559.
43. Streja E., Molnar M.Z., Kovesdy C.P., et al. Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol 2011, 6:1463-1473.
44. Molnar M.Z., Streja E., Kovesdy C.P., et al. Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients. Am J Transplant 2011, 11:725-736.
45. Segev D.L., Massie A.B., Schold J.D., Kaplan B. If you're not fit, you mustn't quit: observational studies and weighing the evidence. Am J Transplant 2011, 11:652-653.
46. Alexander J.W., Goodman H. Gastric bypass in chronic renal failure and renal transplant. Nutr Clin Pract 2007, 22:16-21.
47. Modanlou K.A., Muthyala U., Xiao H., et al. Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation 2009, 87:1167-1173.
48. Rogers C.C., Alloway R.R., Alexander J.W., Cardi M., Trofe J., Vinks A.A. Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study. Clin Transplant 2008, 22:281-291.
49. Glanton C.W., Kao T.C., Cruess D., Agodoa L.Y., Abbott K.C. Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index. Kidney Int 2003, 63:647-653.
50. Evans S., Michael R., Wells H., et al. Drug interaction in a renal transplant patient: cyclosporin-Neoral and orlistat. Am J Kidney Dis 2003, 41:493-496.
51. Praga M., Hernandez E., Andres A., Leon M., Ruilope L.M., Rodicio J.L. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron 1995, 70:35-41.